Analisis Utilitas Dan Biaya Terapi Pada Pasien Penyakit Ginjal Kronik Di RSUD Dr Moewardi Surakarta

Hapsari, Estuningtyas Ayu and , Tri Murti Andayani.,Sp.FRS., Ph.D.,Apt (2020) Analisis Utilitas Dan Biaya Terapi Pada Pasien Penyakit Ginjal Kronik Di RSUD Dr Moewardi Surakarta. Thesis thesis, Universitas Muhammadiyah Surakarta.

	PDF (Naskah Publikasi) naskah publikasi.pdf Download (1MB)
	PDF (Halaman Depan) Halaman Depan-4.pdf Download (1MB)
	PDF (Bab I) Bab I.pdf Download (300kB)
	PDF (Bab II) Bab II.pdf Restricted to Repository staff only Download (465kB)
	PDF (Bab III) Bab III.pdf Restricted to Repository staff only Download (463kB)
	PDF (Bab IV) Bab IV.pdf Restricted to Repository staff only Download (413kB)
	PDF (Bab V) Bab V.pdf Restricted to Repository staff only Download (185kB)
	PDF (Daftar Pustaka) Daftar Pustaka.pdf Download (481kB)
	PDF (Lampiran) Lampiran.pdf Restricted to Repository staff only Download (1MB)
	PDF (Surat Pernyataan Publikasi) Surat Pernyataan Publikasi Ilmiah.pdf Restricted to Repository staff only Download (189kB)

Abstract

The progressive decline in kidney function can be influenced by the presence of other diseases that come together and the presence of new diseases or health problems caused by CKD (Chronic Kidney Disease). The objectives of the study were to determine the health-related quality of life (HRQoL) and health utility index in patients with chronic kidney disease (CKD), to know the average cost required by chronic kidney disease (CKD) patients and to know the difference in the health utility index and costs patient characteristics and disease characteristics. The inclusion criteria in the study were patients with a diagnosis of CKD and over 19 years of age. Data were taken concurrently to obtain utility data, by conducting interviews with patients and retrospectively to obtain data on costs, patient characteristics, and disease characteristic data, namely comorbidity, complications, stage and the duration of the CKD. The results of the measurement of utility with the Indonesian version of EQ5D5L in CKD patients have an average EQ5D5L utility value of 0.66 ± 0.24 and a VAS (Visual Analog Scale) of 82.07 ± 7.123. The average cost by CKD patients is Rp.616,928.90 / outpatient with the total cost of the total number of outpatients Rp.92,539,335.00, so the total percentage of the average cost per outpatient treatment with the total cost of outpatient care is Rp.0.67% and the largest total cost was the cost of goods / medicine amounting to Rp.63,911,385.00 ± 260,367.17. Based on the results of the analysis, there are differences in utility values based on the characteristics of comorbidity, complications and stage. In the cost analysis, there are differences in costs based on the characteristics of the comorbidity, complications, stage, and duration of CKD patients.

Item Type:	Karya ilmiah (Thesis)
Uncontrolled Keywords:	Chronic kidney disease, quality of life, cost of therapy, EQ5D-5L
Subjects:	R Medicine > R Medicine (General) R Medicine > RS Pharmacy and materia medica
Divisions:	Fakultas Pasca Sarjana > Magister Farmasi
Depositing User:	Unnamed user with username v100160042
Date Deposited:	19 Nov 2020 03:00
Last Modified:	19 Nov 2020 03:01
URI:	http://eprints.ums.ac.id/id/eprint/87699

Actions (login required)

View Item